Importance of MACC1 expression in breast cancer and its relationship with pathological prognostic markers

被引:7
|
作者
Soyleyici, Nevroz A. [1 ]
Aslan, Figen [2 ]
Avcikurt, Ayla S. [3 ]
Akgun, Gizem A. [4 ]
机构
[1] BaliKesir Univ, Inst Hlth Sci, Dept Pathol, Cagis Yerleskesi,Bigadic Yolu 17 Km Altieylul, BaliKesir, Turkey
[2] BaliKesir Univ, Dept Pathol, Sch Med, Cagis Yerleskesi,Bigadic Yolu 17 Km Altieylul, TR-10145 BaliKesir, Turkey
[3] BaliKesir Univ, Sch Med, Dept Med Biol, Cagis Yerleskesi,Bigadic Yolu 17 Km Altieylul, BaliKesir, Turkey
[4] Dumlupinar Univ, Sch Med, Dept Pathol, Merkez Kutahya, Turkey
关键词
Breast cancer; expression; Metastasis Associated Colon Cancer Gene 1; prognostic marker; COLON CANCER-1; POOR-PROGNOSIS; GROWTH-FACTOR; CARCINOMA; MET; ANGIOGENESIS; LEVEL;
D O I
10.4103/IJPM.IJPM_658_19
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Metastasis associated colon cancer gene 1 (MACC1) is a gene that was first described as a c-Met transcription regulator causing the progression of colon cancer. In this study, protein and messenger RNA (mRNA) expression of MACC1 in breast cancer and its relationship with clinicopathological prognostic parameters were investigated. Methods: Sixty-six cases with tumors underwent radical mastectomy for invasive ductal carcinoma and 25 control cases operated for mammoplasty were included in the study. In paraffin blocks of tumor and control tissues, MACC1 expression was investigated by the immunohistochemical method and Real-time polymerase chain reaction (Real-Time PCR). In addition, vascular endothelial growth factor (VEGF) expression was examined immunohistochemically in tumor tissues. The relationship between MACC1 expression in tumor tissues, clinicopathological prognostic parameters, and VEGF was investigated. Results: In this study, protein and mRNA expressions of MACC1 were found to be higher in tumor tissues compared with normal breast tissues. MACC1 protein expression was also associated with significant poor prognostic markers, such as high histologic grade, ER negativity, and HER2 positivity. However, there was no correlation between MACC1 expression and VEGF. Conclusion: According to these results, MACC1 expression may be a marker of breast carcinoma as well as an independent predictor of poor prognosis. In addition, MACC1 may not affect angiogenesis in breast cancer or even if it has an effect, it may not be associated with VEGF. However, it would be appropriate to support these results in a larger series by investigating in vivo and in vitro studies.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 50 条
  • [21] Impact of KRAS signaling on MACC1 expression in colorectal cancer cells
    Ilm, K.
    Kemmner, W.
    Shirasawa, S.
    Sasazuki, T.
    Stein, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 47 - 47
  • [22] Significance of plasma MACC1 levels on the prognostic stratification in patients with colorectal cancer
    Lin, Aifen
    Zhang, Rui-Li
    Zhang, Xia
    He, Xiao-Fang
    Zhang, Jian-Gang
    Yan, Wei-Hua
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (02) : 1598 - 1601
  • [23] Expression of MACC1 and MET in IBD-Associated Colorectal Cancer
    Cao, Wenqing
    Taboada, Sofia
    Ko, Mabel
    Yang, Qi
    Harpaz, Noam
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 : 29 - 29
  • [24] The importance of MACC1 in colon cancer stem cells and adult stem cell signaling
    Hardt, M.
    Lemos, C.
    Schumacher, D.
    Regenbrecht, C.
    Heiden, E.
    Stein, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 8 - 8
  • [25] Investigation of MACC1 Gene Expression in Head and Neck Cancer and Cancer Stem Cells
    Evran, Ebru
    Sahin, Hilal
    Akbas, Kubra
    Cigdem, Sadik
    Gunduz, Esra
    CLINICAL AND INVESTIGATIVE MEDICINE, 2016, 39 (06): : S77 - S81
  • [26] LncRNA MACC1-AS1 associates with DDX5 to modulate MACC1 transcription in breast cancer cells
    Zheng, Guiyu
    Zhu, Yanmei
    Xu, Liqun
    Chen, Shaoying
    Zhang, Xiaona
    Li, Wei
    Chen, Weibin
    Zhou, Yanchun
    Gu, Wei
    ISCIENCE, 2023, 26 (09)
  • [27] MACC1 expression is an indicator of recurrence in early-stage glottic cancer
    Makino, Takuma
    Orita, Yorihisa
    Gion, Yuka
    Tachibana, Tomoyasu
    Takao, Soshi
    Marunaka, Hidenori
    Miki, Kentaro
    Akisada, Naoki
    Akagi, Yusuke
    Yoshino, Tadashi
    Nishizaki, Kazunori
    Sato, Yasuharu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (04) : 392 - 398
  • [28] Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer
    Wang, Zhiqiang
    Cai, Ming
    Weng, Yuan
    Zhang, Fang
    Meng, Dong
    Song, Jun
    Zhou, Huan
    Xie, Zongtao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (08) : 1353 - 1361
  • [29] Evaluating the expression of MACC1 and c-myc in cervical cancer and their correlation
    Zhang, Ying
    He, Xiaolin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (06): : 5960 - 5966
  • [30] Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma
    Jiliang Qiu
    Pinzhu Huang
    Qian Liu
    Jian Hong
    Binkui Li
    Canliang Lu
    Li Wang
    Jianping Wang
    Yunfei Yuan
    Journal of Translational Medicine, 9